Skip to main content
Clinical Trials/ACTRN12616001172493
ACTRN12616001172493Recruiting未知

Exercise and glycaemic control: A randomised controlled trial examining the role of exercise timing in individuals with Type 2 diabetes mellitus

Murdoch University0 sites60 target enrollmentStarted: August 26, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • T2DM Group:
  • Non-smoking, sedentary (defined as the accrual of less than 150 min of exercise per week) individuals who are overweight (body mass index more than or equal to 27 kg/m2) and have an existing diagnosis of T2DM.
  • Healthy Control Group:
  • Non-smoking, sedentary (defined as the accrual of less than 150 min of exercise per week) individuals who are overweight (body mass index more than or equal to 27 kg/m2)

Exclusion Criteria

  • Participants will not be eligible if: (i) they are unable to complete exercise or have a condition which is known to be aggravated by exercise (assessed using the Exercise and Sports Science Australia pre-exercise screening tool); (ii) they are on insulin; (iii) have had surgery for weight loss; (iv) they had prior history of heart, lung, kidney, endocrine or liver disease; (v) experienced recent weight loss (4 kg or more) in previous month.

Investigators

Similar Trials